No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Noncurrent receivable foreign tax payment. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. Completed factory and warehouse closures. No authoritative reference available. Estimated liability related to Automotive product sale and settlement related to Federal-Mogul bankruptcy. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. No authoritative reference available. Contractual Amounts Of Companys Forward Exchange Contracts. No authoritative reference available. Probable Insurance Recoveries included in Estimated Liability. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Receivables, less allowances. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net income per common share basic and diluted. No authoritative reference available. No authoritative reference available. No authoritative reference available. Components of net income and other nonowner changes in equity net of related taxes. No authoritative reference available. Common stock authorized for purchase. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany accounts receivable. No authoritative reference available. Total estimated insurance recoveries for asbestos claims related to discontinued operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. The amount of goodwill recognized as of the acquisition date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer). No authoritative reference available. Write-off of recognized cumulative currency translation losses related to formation of Tools Joint Venture. No authoritative reference available. No authoritative reference available. No authoritative reference available. Current recovery of total defense and indemnity payments for Abex claims, in percent. No authoritative reference available. Condensed consolidating balance sheets. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Other noncurrent assets, including other intangible assets. No authoritative reference available. Proceeds from repayment of intercompany loans by consolidated affiliates. No authoritative reference available. Initial payment to Federal-Mogul trust required under Plan A Settlement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Average indemnity payment for resolved Abex Claims. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Condensed consolidating statements of cash flows. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Investments in consolidated affiliates. No authoritative reference available. Intercompany accounts payable. No authoritative reference available. Reduction in income tax expense for discrete items. No authoritative reference available. Cumulative Restructuring Actions. No authoritative reference available. No authoritative reference available. No authoritative reference available. Equity in earnings of consolidated subsidiaries, net of tax. No authoritative reference available. No authoritative reference available. No authoritative reference available. Access to Abex insurance policies with remaining limits, minimum. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Reclassification. No authoritative reference available. Net of Tax Write-off of recognized cumulative currency translation losses related to formation of Tools Joint Venture. No authoritative reference available. This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties. No authoritative reference available. Total write-off of recognized accumulated other nonowner changes in equity related to formation of Tools Joint Venture. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Loss related to contribution of net assets to Tools joint venture. No authoritative reference available. Incremental Restructuring Charges Upper Range. No authoritative reference available. Condensed consolidating statements of income. No authoritative reference available. Investment in parent. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Salaried headcount reductions related to restructuring actions. No authoritative reference available. Subsidiary common stock. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Actual payment received by Company from other party under Plan B Settlement. No authoritative reference available. Amount Of Loan Which Is Partially Paid From The Debt. No authoritative reference available. No authoritative reference available. No authoritative reference available. Proceeds from issuance of stock to consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Investment in consolidated subsidiaries. No authoritative reference available. Percentage of total estimated insurance recoveries from Insurers - Credit rating of A - or better. No authoritative reference available. No authoritative reference available. No authoritative reference available. Other cash activity associated with asbestos claims related to discontinued operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element is used to disclose the entity's entire derivative instruments and hedging activities disclosure and complete disclosure regarding the fair value of financial instruments and the measurements of those instruments, assets, and liabilities as a single block of text. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany income (expense). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Value of share repurchases subsequent to balance sheet date through filing date. No authoritative reference available. Incremental Restructuring Charges Lower Range. No authoritative reference available. Interest received by Cooper related to Federal-Mogul Plan B Settlement payment. No authoritative reference available. No authoritative reference available. No authoritative reference available. Interest on income tax assessment. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of shares expected to be repurchased to offset dilution from share issuances under equity compensation plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Description of assets and liabilities of Tools Business that are held for sale in connection with the formation of a Joint Venture. No authoritative reference available. Restricted stock units granted No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Common shares issued for employee incentive, benefit plans and dividend reinvestment program. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Potential additional Plan A Settlement payment over 25 years. No authoritative reference available. Number of Abex Asbestos Claims Pending At End Of Period. No authoritative reference available. No authoritative reference available. No authoritative reference available. Portion of total estimated asbestos related insurance receivables for previously paid claims and insurance settlements. No authoritative reference available. Hourly headcount reductions related to restructuring actions. No authoritative reference available. The cash outflow to reacquire common stock during the period to be held in Treasury. No authoritative reference available. No authoritative reference available. No authoritative reference available. Aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Proceeds from insurance recoveries for asbestos claims related to discontinued operations. No authoritative reference available. Total factories and warehouses approved for closure. No authoritative reference available. No authoritative reference available. No authoritative reference available. Payment of income tax, including interest, on assessment. No authoritative reference available. Potential payment to Cooper by Federal-Mogul under Plan B Settlement. No authoritative reference available. No authoritative reference available. No authoritative reference available. Restructuring Reserve Headcounts EndingBalance Headcount. No authoritative reference available. No authoritative reference available. No authoritative reference available. Reduction in income tax expense related to Tools JV Contribution. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Headcount reductions related to restructuring actions. No authoritative reference available. Range of potential estimates of undiscounted liability related to Abex asbestos claims, minimum. No authoritative reference available. Basis of Presentation. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Performance-based shares and restricted stock units available for future grants. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Percentage Of Debt Of Hedged Item. No authoritative reference available. Estimated undiscounted liability for pending and future indemnity and defense costs related to Abex asbestos claims for the next 45 years. No authoritative reference available. Defense costs incurred related to Abex asbestos claims for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Repayment of borrowings from intercompany loans with consolidated affiliates. No authoritative reference available. Cash Activity Under Plan Settlement Text Block. No authoritative reference available. Carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). No authoritative reference available. No authoritative reference available. No authoritative reference available. Effective tax rate after excluding the impact of the discrete items. No authoritative reference available. Proceeds from borrowings from intercompany loans with consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net cash flow related to the entity's discontinued operations assets and liabilities No authoritative reference available. No authoritative reference available. No authoritative reference available. Voting interest in the Joint Venture. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total Estimated Undiscounted Liability For Asbestos Claims Related To Discontinued Operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. Portion Of Total Estimated Asbestos Related Insurance Receivables For Pending Claims And Future Claims. No authoritative reference available. No authoritative reference available. No authoritative reference available. Headcount Reductions Expected Related to Restructuring Actions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany notes receivable. No authoritative reference available. No authoritative reference available. No authoritative reference available. Numbers of acquisitions completed during the period. No authoritative reference available. Subsidiary preferred stock. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Net cash provided by or used from consolidated affiliates, excluding intercompany loans. No authoritative reference available. Represents the sum of the carrying value of all the Assets Held-for-Sale at the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Indemnity And Defense Payments For Asbestos Claims Related To Discontinued Operations. No authoritative reference available. No authoritative reference available. No authoritative reference available. Cash used to provide intercompany loans to consolidated affiliates. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Share repurchases subsequent to balance sheet date through filing date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Range of potential estimates of undiscounted liability related to Abex asbestos claims, maximum. No authoritative reference available. No authoritative reference available. No authoritative reference available. Intercompany notes payable. No authoritative reference available. Initial Fair Value of Equity Investment in Apex Tool Group. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Component of net inventories. No authoritative reference available. Separate Assets And Liabilities Under Plan Settlement Text Block. No authoritative reference available. No authoritative reference available. No authoritative reference available. Gain from the contribution to the Joint Venture resulting from the difference in the fair value of the equity investment, net of transaction related costs, and the carrying value of the net assets being contributed. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). No authoritative reference available. Number of Abex asbestos claims filed for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Additional Shares Repurchased Under Authorizations. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of Abex asbestos claims resolved for the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Components of the assets and liabilities to be contributed to Tools Joint Venture. No authoritative reference available. No authoritative reference available. No authoritative reference available. Liability (such as a mortgage) related to a disposal group that is held for sale and anticipated to be sold in less than one year. The liability is expected to be discharged as part of the plan of sale for the asset. No authoritative reference available. The net cash provided by (used in) the operating activities of the entity's discontinued operations assets and liabilities. No authoritative reference available. No authoritative reference available. No authoritative reference available.